UY24733A1 - Nuevos compuestos - Google Patents

Nuevos compuestos

Info

Publication number
UY24733A1
UY24733A1 UY24733A UY24733A UY24733A1 UY 24733 A1 UY24733 A1 UY 24733A1 UY 24733 A UY24733 A UY 24733A UY 24733 A UY24733 A UY 24733A UY 24733 A1 UY24733 A1 UY 24733A1
Authority
UY
Uruguay
Prior art keywords
new compounds
alkyl
aryl
heterocycles
quinoline
Prior art date
Application number
UY24733A
Other languages
English (en)
Spanish (es)
Inventor
Carlo Dr Farina
Giuseppe Dr Giardina
Mario Grugni
Luca Francesco Raveglia
Original Assignee
Smithkline Beecham Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT95MI002461 external-priority patent/IT1276170B1/it
Priority claimed from IT96MI001689 external-priority patent/IT1307331B1/it
Application filed by Smithkline Beecham Spa filed Critical Smithkline Beecham Spa
Publication of UY24733A1 publication Critical patent/UY24733A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UY24733A 1995-11-24 1997-09-30 Nuevos compuestos UY24733A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI002461 IT1276170B1 (it) 1995-11-24 1995-11-24 Derivati chinolinici
IT96MI001689 IT1307331B1 (it) 1996-08-02 1996-08-02 Derivati chinolinici

Publications (1)

Publication Number Publication Date
UY24733A1 true UY24733A1 (es) 2001-08-27

Family

ID=26331326

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24733A UY24733A1 (es) 1995-11-24 1997-09-30 Nuevos compuestos

Country Status (26)

Country Link
US (1) US6277862B1 (2)
EP (1) EP0876347B1 (2)
JP (1) JP2000501104A (2)
KR (1) KR19990071597A (2)
CN (1) CN1207730A (2)
AP (1) AP9801237A0 (2)
AR (1) AR004972A1 (2)
AT (1) ATE289994T1 (2)
BG (1) BG102558A (2)
BR (1) BR9611820A (2)
CA (1) CA2238298A1 (2)
CZ (1) CZ157998A3 (2)
DE (1) DE69634416T2 (2)
EA (1) EA002124B1 (2)
ES (1) ES2236757T3 (2)
IL (1) IL124522A0 (2)
MX (1) MX9804107A (2)
NO (1) NO311212B1 (2)
NZ (1) NZ323387A (2)
OA (1) OA11010A (2)
PL (1) PL326967A1 (2)
SK (1) SK66798A3 (2)
TR (1) TR199800924T2 (2)
TW (1) TW353066B (2)
UY (1) UY24733A1 (2)
WO (1) WO1997021680A1 (2)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119155C (en) * 1991-10-18 1999-06-15 Dennis Paul Phillion Fungicides for the control of take-all disease of plants
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
GB9825554D0 (en) * 1998-11-20 1999-01-13 Smithkline Beecham Spa Novel Compounds
US7037922B1 (en) 2000-03-10 2006-05-02 Neurogen Corporation Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands
JP2002540203A (ja) 1999-03-29 2002-11-26 ニューロゲン コーポレイション Nk−3および/またはgaba(a)受容体リガンドとしての4−置換キノリン誘導体
WO2000064877A1 (en) 1999-04-26 2000-11-02 Neurogen Corporation 2-aminoquinolinecarboxamides: neurokinin receptor ligands
ES2254688T3 (es) * 2001-04-11 2006-06-16 Glaxosmithkline S.P.A. Derivados de quinolina-4-carboxamida como antagonistas de los receptores nk-3 y nk-2.
AU2002259147A1 (en) * 2001-05-08 2002-11-18 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
SG168407A1 (en) 2003-01-28 2011-02-28 Ironwood Pharmaceuticals Inc Methods and compositions for the treatment of gastrointestinal disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
GB0303086D0 (en) 2003-02-11 2003-03-19 Merck Sharp & Dohme New compounds
GB0419192D0 (en) 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
AU2005304962B2 (en) * 2004-11-09 2009-11-19 Smithkline Beecham Corporation Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
GB0425077D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
GB0515580D0 (en) 2005-07-29 2005-09-07 Merck Sharp & Dohme Therapeutic compounds
JP2009504641A (ja) * 2005-08-11 2009-02-05 アストラゼネカ・アクチエボラーグ Nk−3受容体の調節剤としてのアルキルピリジルキノリン
AR057130A1 (es) 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
TW200804288A (en) * 2005-12-12 2008-01-16 Astrazeneca Ab Alkylsulphonamide quinolines
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
KR20100075568A (ko) * 2007-09-28 2010-07-02 글락소스미스클라인 엘엘씨 글리코겐 포스포릴라아제 억제제 화합물 및 이의 약제 조성물
KR20100087300A (ko) * 2007-09-28 2010-08-04 글락소스미스클라인 엘엘씨 글리코겐 포스포릴라아제 억제제 화합물 및 이의 약학적 조성물
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
SI2384318T1 (en) 2008-12-31 2018-03-30 Ardelyx, Inc. MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX366293B (es) 2012-08-21 2019-07-04 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
LT2983667T (lt) 2013-04-12 2019-07-10 Ardelyx, Inc. Nhe3 rišantys junginiai ir fosfato pernešimo slopinimo būdai
CA2909752A1 (en) 2013-04-19 2014-10-23 Astrazeneca Ab A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos)
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
WO2017072629A1 (en) 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical combination of nk3 receptor antagonist and biguanides
EA201991676A1 (ru) 2017-01-09 2020-01-30 Арделикс, Инк. Ингибиторы nhe-опосредованного антипорта
CA3049678A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) * 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
JPS6399057A (ja) * 1986-06-27 1988-04-30 Nippon Shinyaku Co Ltd グリシン誘導体
DK0804419T3 (da) * 1994-05-27 2003-11-24 Glaxosmithkline Spa Quinolinderivater som tachykinin NK 3-receptor-antagonister
IT1270615B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Uso di derivati di chinolina

Also Published As

Publication number Publication date
WO1997021680A1 (en) 1997-06-19
NO982331L (no) 1998-07-22
TR199800924T2 (xx) 1998-08-21
NO311212B1 (no) 2001-10-29
CN1207730A (zh) 1999-02-10
DE69634416D1 (de) 2005-04-07
IL124522A0 (en) 1998-12-06
DE69634416T2 (de) 2005-12-29
US6277862B1 (en) 2001-08-21
PL326967A1 (en) 1998-11-09
KR19990071597A (ko) 1999-09-27
EA199800477A1 (ru) 1998-12-24
NO982331D0 (no) 1998-05-22
TW353066B (en) 1999-02-21
EP0876347A1 (en) 1998-11-11
AR004972A1 (es) 1999-04-07
ATE289994T1 (de) 2005-03-15
MX9804107A (es) 1998-09-30
BR9611820A (pt) 1999-07-13
BG102558A (bg) 1999-03-31
JP2000501104A (ja) 2000-02-02
AP9801237A0 (en) 1998-06-30
OA11010A (en) 2003-03-06
SK66798A3 (en) 1999-01-11
NZ323387A (en) 2000-02-28
EP0876347B1 (en) 2005-03-02
ES2236757T3 (es) 2005-07-16
CA2238298A1 (en) 1997-06-19
EA002124B1 (ru) 2001-12-24
CZ157998A3 (cs) 1998-12-16

Similar Documents

Publication Publication Date Title
UY24733A1 (es) Nuevos compuestos
ATE240734T1 (de) Zubereitung von xanthinderivaten als feste dispersion
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
DK0421364T3 (da) Pleuromutiliner
FR2733244B1 (fr) Systeme de stabilisants a base de derives de polyalkylpiperidine
FI971635L (fi) Menetelmät neuropeptidiin Y liittyvien tilojen inhiboimiseksi
ATE297898T1 (de) 4-carboxamino-2-subsitutierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
ATE277906T1 (de) 4-carboxamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
DE69533277D1 (de) Dc-89 derivat
EA200101133A1 (ru) Способ ингибирования агрегации амилоидных белков и визуализации амилоидных отложений с использованием производных изоиндолина
DK0984778T3 (da) Neuropeptid-Y-ligander
DE69112353D1 (de) Verfahren zur regelung der arbeitsbedingungen einer spritzgiessmaschine.
EP1029860A4 (en) BENZOFURANE DERIVATIVES
DE69104587D1 (de) Verfahren zum steuern des arbeitszyklus einer spritzgiessmaschine.
DE69100197D1 (de) Verfahren zur verhinderung von hydraten.
ES2131342T3 (es) Inhibidores de metaloproteinasa.
DE69232047D1 (de) Verfahren zum hemmen von bewuchs
MA21980A1 (fr) Herbicides derives de 2 - azolyl nicotinate .
GB9815910D0 (en) Synthetic method
ATE289995T1 (de) Thiazol-derivate als ppar-gamma-ligande
FI914249A7 (fi) Menetelmä taimien tunnistamiseksi
DE59102385D1 (de) Verfahren zum bearbeiten der innenflächen von bohrungen.
DE69625069D1 (de) Insektizide von n-(substituiertes arylmethyl)-4-(bis (substituiertes phenyl oder pyridyl)methyl)-piperidin.
EA200001153A1 (ru) Очистка карбоксальдегида
ATE160357T1 (de) Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130228